CP1
Click for more information
0.00% 17.0¢ cannpal animal therapeutics limited

There should be quite a bit of news to follow over next few...

  1. StockObserver
    1,308 Posts.
    lightbulb Created with Sketch. 582
    clock Created with Sketch.
    16/09/19
    22:16
    Post #: 40443756
    There should be quite a bit of news to follow over next few months. FDA (INAD) application, CSRIO collaboration, CPAT-01 trial update/result read out, DermaCann trial and possible distribution agreements.

    I suspect things could heat up for CP1 in the coming months.

    All IMO. DYOR
    CP1 Price at posting: 16.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 1  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

AWJ Jeffrey's Find delivered $6.3M in gold sales for August, says Auric
right-arrow Created with Sketch.
IMD IMDEX to receive $10M in out-of-court settlement with Boart Longyear over downhole tool patent
right-arrow Created with Sketch.
G88 Golden Mile ditches Marble Bar and Murchison tenements after weak fieldwork results
right-arrow Created with Sketch.
NEWS Appliances and furnishings impress - will Harvey Norman be next?
right-arrow Created with Sketch.
WNX Wellnex sees first special access scheme prescriptions for new Wellness Life brand
right-arrow Created with Sketch.
MOV MOVE Logistics picks new interim CEO to take over operations from early September
right-arrow Created with Sketch.
watchlist Created with Sketch. Add CP1 (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.